These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 6147080)

  • 1. Bucindolol, a beta-adrenoceptor blocker with vasodilatory action: its effect in systemic hypertension.
    Rotmensch HH; Rocci ML; Vlasses PH; Swanson BN; Fedder IL; Soyka L; Ferguson RK
    Am J Cardiol; 1984 Aug; 54(3):353-6. PubMed ID: 6147080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of single doses of bucindolol and oxprenolol in hypertensive patients.
    Webster J; Petrie JC; Robb OJ; Jamieson M; Verschueren J
    Br J Clin Pharmacol; 1985 Oct; 20(4):393-400. PubMed ID: 2866786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bucindolol in essential hypertension.
    Reid JL; Curzio J; Vincent J
    Int J Clin Pharmacol Res; 1985; 5(5):293-301. PubMed ID: 2866166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative beta-adrenoceptor blocking effect and pharmacokinetics of bucindolol and propranolol in man.
    Maury M; Berdeaux A; Kher A; Duhaze P; Giudicelli JF
    Eur J Clin Pharmacol; 1985; 27(6):649-56. PubMed ID: 2859199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term beta-blocker vasodilator therapy improves cardiac function in idiopathic dilated cardiomyopathy: a double-blind, randomized study of bucindolol versus placebo.
    Gilbert EM; Anderson JL; Deitchman D; Yanowitz FG; O'Connell JB; Renlund DG; Bartholomew M; Mealey PC; Larrabee P; Bristow MR
    Am J Med; 1990 Mar; 88(3):223-9. PubMed ID: 1968710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic effects during rest and exercise of bucindolol in hypertensive men.
    Conner DP; Vlasses PH; Clementi RA; Oren A; Deitchman D; Ferguson RK
    J Clin Pharmacol; 1987 Apr; 27(4):300-3. PubMed ID: 2890669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of timolol and hydrochlorothiazide on blood-pressure and plasma renin activity. Double-blind factorial trial.
    Chalmers J; Tiller D; Horvath J; Bune A
    Lancet; 1976 Aug; 2(7981):328-31. PubMed ID: 60566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short- and long-term studies of bucindolol in mild to moderate hypertension: efficacy, safety, and exercise responses.
    Rosendorff C; Goodman C; Coull A
    J Clin Pharmacol; 1985 Apr; 25(3):233-6. PubMed ID: 2860134
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy of bucindolol in systemic hypertension.
    Kimura S; DeQuattro V; Edmiston WA; Loo R; Thien S; Rigonan K; Deitchman D; Foti A
    Am J Cardiol; 1987 Nov; 60(13):1083-6. PubMed ID: 2890292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diuretics, beta-blockers or both as treatment for essential hypertension.
    Stumpe KO; Overlack O
    Br J Clin Pharmacol; 1979; 7 Suppl 2(Suppl 2):189S-197S. PubMed ID: 37874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute effects of prizidilol on blood pressure, heart rate, catecholamines, renin and aldosterone in essential hypertension.
    Bianchetti MG; Boehringer K; Weidmann P; Link L; Schiffl H; Ziegler WH
    Eur J Clin Pharmacol; 1982 Oct; 23(4):289-96. PubMed ID: 6129141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of carvedilol on blood pressure in patients with mild to moderate hypertension. A dose response study.
    McPhillips JJ; Schwemer GT; Scott DI; Zinny M; Patterson D
    Drugs; 1988; 36 Suppl 6():82-91. PubMed ID: 2908306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bucindolol, systolic blood pressure, and outcomes in systolic heart failure: a prespecified post hoc analysis of BEST.
    White M; Desai RV; Guichard JL; Mujib M; Aban IB; Ahmed MI; Feller MA; de Denus S; Ahmed A
    Can J Cardiol; 2012 May; 28(3):354-9. PubMed ID: 21982425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical evaluation of penbutolol (Hoe 893d) (beta adrenergic blocker), alone and in combination with hydrochlorothiazide, in the treatment of arterial hypertension. II. Effect on plasma electrolytes, renal function, plasma renin and aldosterone activity and risk factors, including plasma lipids].
    Ocón J; Piña C; Castellet R; Vila R; del Río G; Arnau C
    Med Clin (Barc); 1985 Jun; 85(2):53-7. PubMed ID: 3894828
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of intrinsic sympathomimetic activity of bucindolol and carvedilol in rat heart.
    Willette RN; Mitchell MP; Ohlstein EH; Lukas MA; Ruffolo RR
    Pharmacology; 1998 Jan; 56(1):30-6. PubMed ID: 9467185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The renin-aldosterone system in essential hypertension--hypotensive action of beta adrenergic blocking agents and variation of the renin-aldosterone system (author's transl)].
    Hata S
    Nihon Naibunpi Gakkai Zasshi; 1977 Oct; 53(10):1129-39. PubMed ID: 22466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-response of chronic beta-blocker treatment in heart failure from either idiopathic dilated or ischemic cardiomyopathy. Bucindolol Investigators.
    Bristow MR; O'Connell JB; Gilbert EM; French WJ; Leatherman G; Kantrowitz NE; Orie J; Smucker ML; Marshall G; Kelly P
    Circulation; 1994 Apr; 89(4):1632-42. PubMed ID: 7908610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of bucindolol on neurohormonal activation in congestive heart failure.
    Eichhorn EJ; McGhie AL; Bedotto JB; Corbett JR; Malloy CR; Hatfield BA; Deitchman D; Willard JE; Grayburn PA
    Am J Cardiol; 1991 Jan; 67(1):67-73. PubMed ID: 1670902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-ranging study of the new beta-adrenergic antagonist nadolol in the treatment of essential hypertension.
    Frithz G
    Curr Med Res Opin; 1978; 5(5):383-7. PubMed ID: 26519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihypertensive and humoral effects of nifedipine in essential hypertension uncontrolled by hydrochlorothiazide alone.
    Opsahl JA; Halstenson CE; Abraham PA
    Am J Hypertens; 1989 Nov; 2(11 Pt 1):828-33. PubMed ID: 2686710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.